350. Dundee J, Lilburn J: Ketamine-lorazepam: Attenua-
tion of the psychic sequelae of ketamine by loraze-
pam. Anaesthesia 37:312, 1977.
351. Kothary S, Zsigmond E:A double-blind study of the
effective anti-hallucinatory doses of diazepam prior
to ketamine anesthesia. Clin Pharmacol Ther
21:108, 1977.
352. Doenicke A, Angster R, Mayer M, et al: [The action
of S-(+)-ketamine on serum catecholamine and
cortisol: A comparison with ketamine racemate].
Anaesthetist 41:597–603, 1992.
353. Soliman M, Brinale G, Kuster G: Response to
hypercapnia under ketamine anaesthesia. Can
Anaesth Soc J 22:486, 1975.
354. Dillon J: Clinical experience with repeated keta-
mine administration for procedures requiring anes-
thesia.
In
Kreuscher H (ed): Ketamine. Berlin,
Springer-Verlag, 1969.
355. Hamza J, Ecoffey C, Gross JB: Ventilatory response
to CO
2
following intravenous ketamine in children.
Anesthesiology 70:422–425, 1989.
356. Corssen G, Gutierrez J, Reves JG, Huber FC Jr:
Ketamine in the anesthetic management of asthma-
tic patients. Anesth Analg 51:588–596, 1972.
357. Hirshman CA,Downes H,FarboodA,Bergman NA:
Ketamine block of bronchospasm in experimental
canine asthma. Br J Anaesth 51:713–718, 1979.
358. Wanna HT, Gergis SD: Procaine, lidocaine, and
ketamine inhibit histamine-induced contracture of
guinea pig tracheal muscle in vitro. Anesth Analg
57:25–27, 1978.
359. Sarma VJ: Use of ketamine in acute severe asthma.
Acta Anaesthesiol Scand 36:106–107, 1992.
360. Sonntag H, Heiss HW, Knoll D, et al: [Myocardial
perfusion and myocardial oxygen consumption in
patients during the induction of anesthesia using
dehydrobenzperidol-fentanyl or ketamine]. Z
Kreislaufforsch 61:1092–1105, 1972.
361. Zsigmond E,Domino E: Clinical pharmacology and
current uses of ketamine.
In
Aldrete J, Stanley
T (eds): Trends in Intravenous Anesthesia. Chicago,
Year Book, 1980, p 283.
362. Savege TM, Colvin MP, Weaver EJ, et al: A compa-
rison of some cardiorespiratory effects of althesin
and ketamine when used for induction of anaesthe-
sia in patients with cardiac disease. Br J Anaesth
48:1071–1081, 1976.
363. Morray JP, Lynn AM, Stamm SJ, et al: Hemodyna-
mic effects of ketamine in children with congenital
heart disease. Anesth Analg 63:895–899, 1984.
364. Greeley WJ, Bushman GA, Davis DP, Reves JG:
Comparative effects of halothane and ketamine on
systemic arterial oxygen saturation in children with
cyanotic heart disease. Anesthesiology 65:666–668,
1986.
365. Ogawa A, Uemura M, Kataoka Y, et al: Effects of
ketamine on cardiovascular responses mediated by
N
-methyl-d-aspartate receptor in the rat nucleus
tractus solitarius. Anesthesiology 78:163–167,
1993.
366. Ivankovich AD, Miletich DJ, Reimann C, et al: Car-
diovascular effects of centrally administered keta-
mine in goats. Anesth Analg 53:924–933, 1974.
367. Balfors E, Haggmark S, Nyhman H, et al: Droperi-
dol inhibits the effects of intravenous ketamine on
central hemodynamics and myocardial oxygen con-
sumption in patients with generalized atherosclero-
tic disease. Anesth Analg 62:193–197, 1983.
368. Pagel PS, Kampine JP, Schmeling WT, Warltier DC:
Ketamine depresses myocardial contractility as eva-
luated by the preload recruitable stroke work rela-
tionship in chronically instrumented dogs with
autonomic nervous system blockade. Anesthesio-
logy 76:564–572, 1992.
369. Urthaler F, Walker A, James T: Comparison of the
inotropic action of morphine and ketamine studied
in canine cardiac muscle. J Thorac Cardiovasc Surg
72:142, 1976.
370. Stowe DF, Bosnjak ZJ, Kampine JP: Comparison of
etomidate, ketamine, midazolam, propofol, and
thiopental on function and metabolism of isolated
hearts. Anesth Analg 74:547–558, 1992.
371. Endou M, Hattori Y, Nakaya H, et al: Electrophy-
siologic mechanisms responsible for inotropic res-
ponses to ketamine in guinea pig and rat
myocardium. Anesthesiology 76:409–418, 1992.
372. Salt PJ, Barnes PK, Beswick FJ: Inhibition of neuro-
nal and extraneuronal uptake of noradrenaline by
ketamine in the isolated perfused rat heart. Br J
Anaesth 51:835–838, 1979.
373. Reves J, Flezzani P, Kissin I: Pharmacology of intra-
venous anesthetic induction drugs.
In
Kaplan J (ed):
Cardiac Anesthesia. Orlando, FL, Grune & Stratton,
1987, p 125.
374. Munro HM, Sleigh JW, Paxton LD: The cardiovascu-
lar response to ketamine: The effects of clonidine and
lignocaine. Acta Anaesthesiol Scand 37:75–78, 1993.
375. Hatano S, Keane D, Boggs R: Diazepam-ketamine
anaesthesia for open heart surgery: A «micro-mini»
drip administration technique. Can J Anaesth
23:648, 1976.
376. BidwalA,Stanley T,Graves C:The effects of ketamine
on cardiovascular dynamics during halothane and
enflurane anesthesia. Anesth Analg 54:588, 1975.
377. Corssen G, Reves J, Carter J: Neuroleptanesthesia,
dissociative anesthesia, and hemorrhage. Int Anes-
thesiol Clin 12:145, 1974.
378. Van der Linden P, Gilbart E, Engelman E, et al:
Comparison of halothane, isoflurane, alfentanil,
and ketamine in experimental septic shock. Anesth
Analg 70:608–617, 1990.
379. Kingston H, Bretherton K, Holloway A: A compari-
son between ketamine and diazepam as induction
agents for pericardectomy. Anaesth Intensive Care
6:66, 1978.
380. Fletcher JE, Rosenberg H, Lizzo FH: Effects of dro-
peridol, haloperidol and ketamine on halothane,
succinylcholine and caffeine contractures: Implica-
tions for malignant hyperthermia. Acta Anaesthe-
siol Scand 33:187–192, 1989.
381. Raza SM, Masters RW, Zsigmond EK: Haemodyna-
mic stability with midazolam-ketamine-sufentanil
analgesia in cardiac surgical patients. Can J Anaesth
36:617–623, 1989.
382. Elia N, Tramer MR: Ketamine and postoperative
pain—a quantitative systematic review of randomi-
sed trials. Pain 113:61–70, 2005.
383. Sveticic G, Gentilini A, Eichenberger U, et al: Com-
binations of morphine with ketamine for patient-
controlled analgesia: A new optimization method.
Anesthesiology 98:1195–1205, 2003.
384. Adam F, Chauvin M, Du Manoir B, et al: Small-dose
ketamine infusion improves postoperative analge-
sia and rehabilitation after total knee arthroplasty.
Anesth Analg 100:475–480, 2005.
385. Visser E,Schug SA:The role of ketamine in painmana-
gement. Biomed Pharmacother 60:341–348, 2006.
386. Lavand’homme P, De Kock M,Waterloos H: Intrao-
perative epidural analgesia combined with keta-
mine provides effective preventive analgesia in
patients undergoing major digestive surgery. Anes-
thesiology 103:813–820, 2005.
387. Suzuki M, Haraguti S, Sugimoto K, et al: Low-dose
intravenous ketamine potentiates epidural analgesia
after thoracotomy.Anesthesiology 105:111–119, 2006.
388. Eisenach JC,Yaksh TL: Epidural ketamine in healthy
children—what’s the point? Anesth Analg 96:626,
2003, author reply 627.
389. Groeneveld A, Inkson T: Ketamine: A solution to
procedural pain in burned children. Can Nurse
88:28–31, 1992.
390. Thompson G, Moore D: Ketamine, diazepam, and
Innovar: A computerized comparative study.
Anesth Analg 50:458, 1971.
391. Korttila K, Levanen J: Untoward effects of ketamine
combined with diazepam for supplementing con-
duction anaesthesia in young and middle-aged
adults. Acta Anaesthesiol Scand 22:640–648, 1978.
392. Friedberg BL: Propofol-ketamine technique. Aes-
thetic Plast Surg 17:297–300, 1993.
393. Himmelseher S, Durieux ME: Revising a dogma:
Ketamine for patients with neurological injury?
Anesth Analg 101:524–534, 2005.
394. Fuchs C, Schwabe M: [Rectal premedication using
ketamine-dehydrobenzperidol-atropine in child-
hood]. Anaesthesiol Reanim 15:322–326, 1990.
395. Gutstein HB, Johnson KL, Heard MB, Gregory GA:
Oral ketamine preanesthetic medication in chil-
dren. Anesthesiology 76:28–33, 1992.
396. Tobias JD, Phipps S, Smith B, Mulhern RK: Oral
ketamine premedication to alleviate the distress of
invasive procedures in pediatric oncology patients.
Pediatrics 90:537–541, 1992.
397. Shapiro H: Intracranial hypertension: Therapeutic
and anesthetic considerations. Anesthesiology
43:445, 1971.
398. Reves JG, Lell WA, McCracken LE Jr, et al: Compa-
rison of morphine and ketamine anesthetic techni-
ques for coronary surgery: A randomized study.
South Med J 71:33–36, 1978.
399. Malinovsky JM, Lepage JY, Cozian A, et al: Is keta-
mine or its preservative responsible for neurotoxicity
in the rabbit? Anesthesiology 78:109–115, 1993.
400. Janssen P, Niemegeers J, Schellekens K: Etomidate,
R-(+)-Ethyl-1-(alpha-methyl-benzyl)imidazole-5-
carboxylate (R 16659): A potent, short-acting and
relatively atoxic intravenous hypnotic agent in rats.
Arzneimittelforschung 21:1234, 1971.
401. Ledingham IM, Watt I: Influence of sedation on
mortality in critically ill multiple trauma patients.
Lancet 1:1270, 1983.
402. Wagner RL, White PF: Etomidate inhibits adreno-
cortical function in surgical patients. Anesthesio-
logy 61:647–651, 1984.
403. Longnecker DE: Stress free: To be or not to be?
Anesthesiology 61:643–644, 1984.
404. Owen H, Spence AA: Etomidate. Br J Anaesth
56:555–557, 1984.
405. Doenicke A, Roizen MF, Nebauer AE, et al: A com-
parison of two formulations for etomidate,
2-hydroxypropyl-beta-cyclodextrin (HPCD) and
propylene glycol. Anesth Analg 79:933–939, 1994.
406. Hadzija BW, Lubarsky DA: Compatibility of etomi-
date, thiopental sodium, and propofol injections
with drugs commonly administered during induc-
tion of anesthesia.Am J Health Syst Pharm 52:997–
999, 1995.
407. Nimmo W, Miller M: Pharmacology of etomidate.
In
Brown B (ed): New Pharmacologic Vistas in
Anesthesia. Philadelphia, FA Davis, 1983, p 83.
408. Dundee J, Zacharias M: Etomidate.
In
Dundee J
(ed): Current Topics in Anaesthesia Series 1.
London, Arnold, 1979, p 46.
409. Fragen RJ, Caldwell N: Comparison of a new formu-
lation of etomidate with thiopental—side effects and
awakening times. Anesthesiology 50:242–244, 1979.
410. Giese JL, Stockham RJ, Stanley TH, et al: Etomidate
versus thiopental for induction of anesthesia.
Anesth Analg 64:871–876, 1985.
411. Wells JK: Comparison of ICI 35868, etomidate and
methohexitone for day-case anaesthesia. Br J
Anaesth 57:732–735, 1985.
Anestésicos intravenosos
531
16
Sección II
Farmacología y anestesia
© ELSEVIER. Fotocopiar sin autorización es un delito